Download presentation
Presentation is loading. Please wait.
1
Gestational Trophoblastic Disease
Chapter 22 Gestational Trophoblastic Disease Women’s Hospital, School of Medicine Zhejiang University Xiaodong Cheng
2
Gestational trophoblastic disease
A group of diseases originated from placental trophoblastic cells Gestational trophoblasitc disease (GTD) Hydatidiform mole (complete and partial) Invasive mole Choriocarcinoma Placental-site trophoblastic tumor (PSTT) Gestational trophoblastic neoplasia (GTN) Non-gestational trophoblastic tumor Uncommon, derived from germ cells in ovarian or testicular clinically histologically
3
Development and differentiation of gestational trophoblastic cells
gestational trophoblastic cells evolved from extra-embryonic cells At the time of implantation cytotrophoblast outermost layer of the blastocyst 7-8 days after implantation syncytiotrophoblast implantation site Before villi formation previllous trophoblast 2 weeks after pregnancy, primary villi formation Villous surface villous trophoblast Other parts extravillous trophoblast
5
Development and Differentiation of gestational trophoblastic cells
Cytotrophoblast trophoblast stem cells proliferability and differentiability Syncytiotrophoblast differentiated mature cells synthesize pregnancy-related hormones material exchange between the fetus and the mother Two differentiated forms of Cytotrophoblast villous surface area Syncytiotrophoblast extravillous Intermediate trophoblast
6
Hydatidiform mole
7
Hydatidiform mole Complete moles Partial moles
Hydropic degeneration of all villi Villous edema, trophoblastic hyperplasia, fetal-derived blood vessels disappear in stroma Partial moles combine embryo or fetus Villous edema partially, trophoblastic proliferation lighterly, fetal-derived blood vessels present stroma
8
Partial moles Complete moles
9
Hydatidiform mole Related Factors Complete moles
Area common in Latin America, Asia uncommon in North America and Europe Race differences of the same race in different regions Nutrition and Economy lack of Vit A Age < 20 or >35 years The fertilization of an empty egg the fertilization of an empty egg by a haploid sperm Diploid genome 90% of the time (usually 46,XX) Genomic imprinting disorder
10
Hydatidiform mole Partial moles
high-risk factors are still unknown "Haploid egg" fertilization usually two sperm fertilize a normal egg a triploid karyotype (69 chromosomes ), with the extra haploid set of chromosomes derived from father
11
Comparison of complete and partial hydatidiform moles
Karyotype 46, XX(90%) 46, XY(10%) Triploid (69XXY, 69XXX) Embryo Absent Present Villi Hydropic Few hydropic Trophoblasts Diffuse hyperplasia Mild focal hyperplasia Villus outline regular irregular Blood vessel absence presence
12
Hydatidiform mole Partial moles Clinical Presentation Complete moles
Abnormal vaginal bleeding during early pregnancy( 8-12week) most common symptom Uterine enlargement exceeding normal pregnant uterus Others Abdominal pain Pregnancy-induced hypertension Theca lutein ovarian cyst Hyperthyroidism (CHM) Partial moles Mild symptoms, Confused with abortion easily
13
Hydatidiform mole hCG regression pattern after hydatidiform
Mean time of the hCG regressed to normal — 9 weeks no more than 14 weeks Abnormal hCG regression pattern after hydatidiform signifies the presence of GTN Complete mole 15% local invasion and 4% distant metastasis High –risk : ①HCG>100,000U/L ② Enlargement of Uterine ③ Theca lutein ovarian cyst >6cm Partial mole 4%local invasion and almost no distant metastasis High –risk :unclear
14
Hydatidiform mole Diagnosis Abnormal bleeding after amenorrhea
Inappropriately enlarged uterus Absence of fetal heart sounds not palpate fetus between 16-20th week Vaginal discharge hydatidiform-like tissue Hydatidiform mole should be considered
15
Hydatidiform mole Diagnosis Ultrasound HCG DNA karyotype
Complete moles produce a characteristic vesicular sonographic pattern, usually referred to as a “snowstorm” pattern HCG Elevated above expected for gestational age Dynamic observation for 8-10 weeks, continued to rise HCG-related molecules Hyperglycosylated HCG free β-HCG subunit DNA karyotype Complete moles — usually diploid Partial moles — usually triploid
16
a “snowstorm” pattern
17
Hydatidiform mole Treatment Suction curettage
Molar pregnancy should be terminated as soon as possible when diagnosis has been confirmed Suction curettage is a first choice, must be fully done in operating room tissue from curettage should be submitted to pathology
18
Hydatidiform mole Treatment Theca lutein cysts of the ovary
do not need special treatment Prophylactic chemotherapy: A controversial topic only be offered to patients with high-risk factor or impossible follow-up Hysterectomy Only remove local invasion, but not distant metastasis Only for old women without childbearing desire
19
Hydatidiform mole Follow-up necessary for diagnosis of early GTN
Methods: HCG Symptom: Abnormal uterine bleeding Pelvic examination Ultrasound, chest X-ray and CT Contraception: Condom and oral contraceptives, not IUD Duration for contraceptiom — 1 year
20
Gestational Trophoblastic Neoplasia
21
General Consideration
Antecedent gestation 60% hydatidiform mole 30% follow abortion 10% term pregnancy or ectopic pregnancy from mole — invasive mole or choriocarcinoma from Non-mole — choriocarcinoma
22
Gestational Trophoblastic Neoplasia
Pathogenesis Invasive mole Invasive mole is a hydatidiform mole that invades the myometrium and may produce distant metastases. Microscopic finding are the same as in hydatidiform mole Choriocarcinoma Gloss:invades the myometrium , penetrate the serosa and may produce distant metastases Microscopy:no villi, but instead sheets or foci of trophoblasts on a background of hemorrhage and necrosis
23
Invasive mole Choriocarcinoma Invasive mole Choriocarcinoma Invasive mole Choriocarcinoma
24
invades the myometrium Lung metastases Brain metastases
cervical metastases
25
Gestational Trophoblastic Neoplasia
Clinical Manifestation Nonmetastatic GTN the antecedent gestational event is usually HM Abnormal vaginal bleeding after mole Others: Enlarged uterus Theca lutein cysts of the ovary Abdominal pain Fake pregnancy symptoms
26
Gestational Trophoblastic Neoplasia
Metastatic GTN Usually chroriocarcinoma Primary symptoms Metastatic symptoms Lung metastases are frequently common vaginal metastases are the second common liver and brain metastases usually death cause other metastastic sites spleen, kidney, bladder, gastrointestinal system, and bone Simultateously occur or not
27
Gestational Trophoblastic Neoplasia
Diagnosis Symptoms and signs: ◆ Abnormal vaginal bleeding after post-evacuation, abortion, term pregnancy or ectopic pregnancy, ◆ Metastatic symptoms GTT should be considered
28
Gestational Trophoblastic Neoplasia
HCG assay Most important and sometimes only diagnostic evidence Diagnostic criteria for post- HM GTN (FIGO2000) hCG plateau for >4 values (±10%), over 3 weeks hCG increase of ≥10% over 2 weeks hCG persistence after evacuation of mole for 6 months Diagnostic criteria for non post-HM GTN HCG elevated at 4w after abortion, term or ectopic pregnancy Re-rising HCG titer after reaching normal levels
29
Gestational Trophoblastic Neoplasia
Chest X-ray lung metastases CT small lung metastases and brain metastases MRI Liver and brain metastases Ultrasound primary lesions of uterus and pevical metastases Imaging supports diagnosis, but not necessary
30
Gestational Trophoblastic Neoplasia
Histological diagnosis villus shape can be found in primary or metastatical lesions Presence of villus shape Invasive mole Absence of villus shape Choriocarcinoma Histology is not necessary for diagnosis of GTN
31
Anatomy staging of GTN (FIGO, 2000)
Gestational Trophoblastic Neoplasia Anatomy staging of GTN (FIGO, 2000) StageI Localized to the uterus StageII Lesion diffused, but Localized to the genitalia (accessory,vagina,broad ligament) StageIII Lung metastasis, with or without genitalia change StageⅣ Other metastasis Stage III Stage I Stage II Stage IV
32
Prognostic scoring system for GTT (FIGO,2000)
score 1 2 4 Age(y) <40 ≥40 - Antecedent mole abortion term Interval (mo) <4 4~6 7~12 ≥13 Pretreatment b-hCG (mIU/ml) <103 103~104 > 104~105 > 105 Largest tumor (cm) - 3~4 cm ≥5cm Site of metastases Lung Spleen, Kidney Gastrointestinal Liver, brain Number of metastases 1~4 5~8 >8 Prior chemotherapy failed single >2 * Total score≤6 low risk, ≥7 high risk
33
Gestational Trophoblastic Neoplasia
Treatment Chemotherapy combining surgery, radiotherapy and other treatment Base on the assessment and stage, therapy stratified Chemotherapy : Single-agent chemotherapy is applied in low-risk gestational trophoblastic disease (MTX, Act-D, 5-Fu) High-risk patients commonly use combined chemotherapy (EMA-CO)
34
Single agent chemotherapy
DAY Therapy Interval MTX 0.4mg/kg im qd d 1、3、5、 MTX1mg/kg im d 2、4、6、 FA 0.1mg/kg im or po Act-D10-12ug/kg ivgtt qd d Fu mg/kg ivgtt qd -14d
35
Combined chemotherapy
Drugs Dose ,pathway,periods Interval 5-Fu+KSM 3weeks 5-Fu 26-28mg/kg·d,ivgtt for 8days KSM 6g/kg·d, ivgtt for 8days
36
Combined chemotherapy
EMA-CO Interval 2weeks the first part EMA 1st day VP16 100mg/m2 ivgtt Act-D 0.5mg ivgtt MTX 100 mg/m2 ivgtt MTX 200mg/m2 ivgtt for 12hours 2nd day VP16 100mg/m2,ivgtt Act-D 0.5mg ivgtt CF15mg,im (after 24hours from the use of MTX, once every 12hours,twice) 3rd CF15mg,im,once every 12hours,twice。 4th to 7th rest(no drug) the second part CO 8th day VCR1.0mg/m2, ivgtt CTX600mg/m2, ivgtt
37
PSTT A special type, more rarely in clinic
Most of them have a good prognosis Form the intermediate trophoblast cells Clinical manifestations More common occur at reproductive period women More common occur following term or ectopic pregnancy Abnormal bleeding after amenorrhea
38
PSTT Diagnosis Treatment Surgery is the preferred treatment
HCG was negative HPL mildly elevated Confirmed by histology Treatment Surgery is the preferred treatment Chemotherapy is adjuvant therapy
39
Thank you !
Similar presentations
© 2024 SlidePlayer.com. Inc.
All rights reserved.